These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

263 related articles for article (PubMed ID: 12363116)

  • 1. A randomized, double-blind, placebo-controlled study of the effects of adjunctive paroxetine in panic disorder patients unsuccessfully treated with cognitive-behavioral therapy alone.
    Kampman M; Keijsers GP; Hoogduin CA; Hendriks GJ
    J Clin Psychiatry; 2002 Sep; 63(9):772-7. PubMed ID: 12363116
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Paroxetine, clomipramine, and cognitive therapy in the treatment of panic disorder.
    Bakker A; van Dyck R; Spinhoven P; van Balkom AJ
    J Clin Psychiatry; 1999 Dec; 60(12):831-8. PubMed ID: 10665629
    [TBL] [Abstract][Full Text] [Related]  

  • 3. SECOND-STAGE TREATMENTS FOR RELATIVE NONRESPONDERS TO COGNITIVE BEHAVIORAL THERAPY (CBT) FOR PANIC DISORDER WITH OR WITHOUT AGORAPHOBIA-CONTINUED CBT VERSUS SSRI: A RANDOMIZED CONTROLLED TRIAL.
    Payne LA; White KS; Gallagher MW; Woods SW; Shear MK; Gorman JM; Farchione TJ; Barlow DH
    Depress Anxiety; 2016 May; 33(5):392-9. PubMed ID: 26663632
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Double-blind, fixed-dose, placebo-controlled study of paroxetine in the treatment of panic disorder.
    Ballenger JC; Wheadon DE; Steiner M; Bushnell W; Gergel IP
    Am J Psychiatry; 1998 Jan; 155(1):36-42. PubMed ID: 9433336
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A randomized controlled study of paroxetine and cognitive-behavioural therapy for late-life panic disorder.
    Hendriks GJ; Keijsers GP; Kampman M; Oude Voshaar RC; Verbraak MJ; Broekman TG; Hoogduin CA
    Acta Psychiatr Scand; 2010 Jul; 122(1):11-9. PubMed ID: 19958308
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Do selective serotonin re-uptake inhibitors enhance the efficacy of very brief cognitive behavioral therapy for panic disorder? A pilot study.
    Stein MB; Ron Norton G; Walker JR; Chartier MJ; Graham R
    Psychiatry Res; 2000 Jul; 94(3):191-200. PubMed ID: 10889283
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A randomized, controlled trial of aerobic exercise in combination with paroxetine in the treatment of panic disorder.
    Wedekind D; Broocks A; Weiss N; Engel K; Neubert K; Bandelow B
    World J Biol Psychiatry; 2010 Oct; 11(7):904-13. PubMed ID: 20602575
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Next-step strategies for panic disorder refractory to initial pharmacotherapy: a 3-phase randomized clinical trial.
    Simon NM; Otto MW; Worthington JJ; Hoge EA; Thompson EH; Lebeau RT; Moshier SJ; Zalta AK; Pollack MH
    J Clin Psychiatry; 2009 Nov; 70(11):1563-70. PubMed ID: 19814948
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Efficacy and tolerability of controlled-release paroxetine in the treatment of panic disorder.
    Sheehan DV; Burnham DB; Iyengar MK; Perera P;
    J Clin Psychiatry; 2005 Jan; 66(1):34-40. PubMed ID: 15669886
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Selective serotonin reuptake inhibitors in the treatment of panic disorder and agoraphobia.
    Bakker A; van Balkom AJ; van Dyck R
    Int Clin Psychopharmacol; 2000 Aug; 15 Suppl 2():S25-30. PubMed ID: 11110016
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A double-blind study of the efficacy of venlafaxine extended-release, paroxetine, and placebo in the treatment of panic disorder.
    Pollack MH; Lepola U; Koponen H; Simon NM; Worthington JJ; Emilien G; Tzanis E; Salinas E; Whitaker T; Gao B
    Depress Anxiety; 2007; 24(1):1-14. PubMed ID: 16894619
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Global measures of outcome in a controlled comparison of pharmacological and psychological treatment of panic disorder and agoraphobia in primary care.
    Sharp DM; Power KG; Simpson RJ; Swanson V; Anstee JA
    Br J Gen Pract; 1997 Mar; 47(416):150-5. PubMed ID: 9167318
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Does 5-HT restrain panic? A tryptophan depletion study in panic disorder patients recovered on paroxetine.
    Bell C; Forshall S; Adrover M; Nash J; Hood S; Argyropoulos S; Rich A; Nutt DJ
    J Psychopharmacol; 2002 Mar; 16(1):5-14. PubMed ID: 11949771
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rate of improvement during and across three treatments for panic disorder with or without agoraphobia: cognitive behavioral therapy, selective serotonin reuptake inhibitor or both combined.
    Van Apeldoorn FJ; Van Hout WJ; Timmerman ME; Mersch PP; den Boer JA
    J Affect Disord; 2013 Sep; 150(2):313-9. PubMed ID: 23676529
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Long-term evaluation of paroxetine, clomipramine and placebo in panic disorder. Collaborative Paroxetine Panic Study Investigators.
    Lecrubier Y; Judge R
    Acta Psychiatr Scand; 1997 Feb; 95(2):153-60. PubMed ID: 9065681
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Predictors of outcome of pharmacological and psychological treatment of late-life panic disorder with agoraphobia.
    Hendriks GJ; Keijsers GP; Kampman M; Hoogduin CA; Oude Voshaar RC
    Int J Geriatr Psychiatry; 2012 Feb; 27(2):146-50. PubMed ID: 21452176
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Paroxetine in the treatment of panic disorder. A randomised, double-blind, placebo-controlled study.
    Oehrberg S; Christiansen PE; Behnke K; Borup AL; Severin B; Soegaard J; Calberg H; Judge R; Ohrstrom JK; Manniche PM
    Br J Psychiatry; 1995 Sep; 167(3):374-9. PubMed ID: 7496647
    [TBL] [Abstract][Full Text] [Related]  

  • 18. A randomized trial of cognitive-behavioral therapy or selective serotonin reuptake inhibitor or both combined for panic disorder with or without agoraphobia: treatment results through 1-year follow-up.
    van Apeldoorn FJ; Timmerman ME; Mersch PP; van Hout WJ; Visser S; van Dyck R; den Boer JA
    J Clin Psychiatry; 2010 May; 71(5):574-86. PubMed ID: 20492852
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Influence of personality disorder on the treatment of panic disorder--comparison study.
    Prasko J; Houbová P; Novák T; Záleský R; Espa-Cervená K; Pasková B; Vyskocilová J
    Neuro Endocrinol Lett; 2005 Dec; 26(6):667-74. PubMed ID: 16380683
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The Impact of Personality Pathology on Treatment Outcome in Late-life Panic Disorder.
    Gulpers B; Oude Voshaar R; Kampman M; Verhey F; VAN Alphen S; Hendriks GJ
    J Psychiatr Pract; 2020 May; 26(3):164-174. PubMed ID: 32421288
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.